Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
DC19UI
|
|||
| Drug Name |
SQX770
|
|||
| Synonyms |
2892-62-8; Dibutyl squarate; Squaric acid dibutyl ester; 3,4-dibutoxycyclobut-3-ene-1,2-dione; 3,4-Dibutoxy-3-cyclobutene-1,2-dione; SADBE; Squaric acid dibutylester; 3,4-di-n-Butoxy-3-cyclobutene-1,2-dione; 3-Cyclobutene-1,2-dione, 3,4-dibutoxy-; UNII-4RTO57VG65; CHEBI:53612; 1,2-dibutyl squarate; MFCD00037150; 4RTO57VG65; NSC-113489; Squaric acid dibutyl ester, 97%; NSC 113489; di-n-butyl squarate; squaric-acid-dibutyl-ester; ACMC-209h5p; Epitope ID:115137; SCHEMBL56180; CHEMBL2435707; DTXSID30183113; ZINC1704225; ANW-26507; NSC113489; SBB007902; AKOS002138099; DB12223; DS-3421; MCULE-6075224915; VZ36901; 1,2-dibutoxy-1-cyclobutene-3,4-dione; 1,2-Dibutoxy-1-cyclobutene -3,4-dione; AC-22927; AK106214; P014; SY048874; AM20090383; CS-0041921; D2203; EU-0099926; FT-0614214; ST50331241; tert-Butyl3-chloro-4-oxopiperidine-1-carboxylate; A819679; J-017327; Q26841197
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Herpes simplex virus infection [ICD-11: 1F00; ICD-10: B00; ICD-9: 54] | Phase 2 | [1] | |
| Company |
Squarex
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C12H18O4
|
|||
| Canonical SMILES |
CCCCOC1=C(C(=O)C1=O)OCCCC
|
|||
| InChI |
1S/C12H18O4/c1-3-5-7-15-11-9(13)10(14)12(11)16-8-6-4-2/h3-8H2,1-2H3
|
|||
| InChIKey |
XBRWELTXMQSEIN-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 2892-62-8
|
|||
| PubChem Compound ID | ||||
| ChEBI ID |
CHEBI:53612
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT03521479) A Phase 2, Muti-Center Study of Repeat Dosing of Squaric Acid Dibutyl Ester in Subjects With Herpes Labialis. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.